clinical trial · NCT04905914
Study Of ATRN-119 In Patients With Advanced Solid Tumors
Advanced Solid TumorATRN-119
brief summary
The purpose of this study is to assess the safety and effectiveness of ATRN-119 through the performance of a Phase 1/2a, open-label, safety, PK, and preliminary efficacy study of oral ATRN-119 in patients with advanced solid tumors.
started
Jan 9, 2023
primary completion
Feb 1, 2028
completion
Feb 1, 2028
last updated
Jan 26, 2026
official title
A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, And Preliminary Efficacy Study Of Oral ATRN-119 In Patients With Advanced Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol